In July 2012, the European Commission adopted a proposal for a Regulation on Clinical Trials to resolve a
number of problems identified with the current legislation. In the legislative process this proposal is now subject to
discussions by the European Parliament and the Council representing the 27 Member States and in parallel by all
stakeholders affected by it.
One of the key changes proposed concerns the assessment and decision system for clinical trial applications.
The Commission defines the objectives to be achieved, which will have implications on the national competent
authorities and the review by ethics committees. The workshop is meant to provide a platform for a constructive
discussion on the way ethics committees could act and interact in the future.
Read more: http://www.efgcp.eu/Conference_details.asp?id=336&L1=10&L2=1&TimeRef=1